Abstract
The relevance of protein binding to penetration of beta-lactams into body fluids was investigated by examining the distribution of amoxicillin, ceftriaxone, clavulanic acid, temocillin, and ticarcillin into rabbit peripheral lymph after intravenous administration. The elimination half-lives in rabbit plasma varied between 0.34 h (temocillin) and 1.80 h (ceftriaxone), and the half-lives measured in lymph were similar to those in plasma (0.37 to 1.76 h). The percent penetration (area under the concentration-time curve in lymph/area under the concentration-time curve in plasma x 100) was high for amoxicillin (97.6%), temocillin (89.4%), and clavulanic acid (90.8%) but was lower for ticarcillin (76.0%) and for ceftriaxone (67.3%). There was a direct correlation between plasma protein binding and percent penetration. Correction for plasma and tissue binding increased the percent penetration for all compounds, and figures approached 100%. The results presented demonstrate the use of this model to examine the relationships between plasma pharmacokinetics, protein binding, and distribution of antibiotics.
References
Nov 1, 1990·The Journal of Antimicrobial Chemotherapy·G WoodnuttL Mizen
Apr 1, 1989·Journal of Chemotherapy·T Mazzei, P Periti
Jul 1, 1987·Reviews of Infectious Diseases·T BerganW Olszewski
May 1, 1988·Journal of Pharmaceutical Sciences·P J McNamaraK Stoeckel
Jan 1, 1986·Scandinavian Journal of Infectious Diseases·D M RyanB Hoffstedt
Jan 1, 1985·The Journal of Antimicrobial Chemotherapy·M Barza, G Cuchural
Jan 1, 1985·Drugs·D OverboschH Mattie
Dec 1, 1969·The Journal of Physiology·G P Lewis
Aug 1, 1970·British Journal of Pharmacology·S BoylesB Westcott
Aug 1, 1983·The Journal of Antimicrobial Chemotherapy·R Wise
May 1, 1980·Reviews of Infectious Diseases·L R Peterson, D N Gerding
Jan 1, 1981·Reviews of Infectious Diseases·T Bergan
May 1, 1981·Clinical Pharmacology and Therapeutics·K StoeckelW H Ziegler
Sep 1, 1982·The Journal of Infectious Diseases·L L Van EttaD N Gerding
May 1, 1993·The Journal of Antimicrobial Chemotherapy·D M Ryan
Citations
May 5, 1998·Life Sciences·M MüllerH G Eichler
Mar 5, 2002·Journal of Veterinary Pharmacology and Therapeutics·M RebueltoR Hallu
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·William R HumphreyIvan M Richards
May 21, 2010·Journal of Inflammation·Maria SaroglouDemosthenes Bouros
Oct 15, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D K WalkerH F Small
Feb 24, 2006·Respiratory Medicine·Toshiaki NiwaMakoto Itoh
Apr 5, 2013·Clinical Microbiology Reviews·Daniel GonzalezHartmut Derendorf
Jun 12, 2019·Journal of Veterinary Pharmacology and Therapeutics·Benjamin KimbleMerran Govendir
Sep 27, 2002·BMC Clinical Pharmacology·David G Levitt
Dec 10, 2020·CPT: Pharmacometrics & Systems Pharmacology·Patrick O HanafinGauri G Rao